Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

Available NCT07104591

TETRAVI Expanded Access Program

Conditions: Epstein-Barr Virus Infection, Cytomegalovirus Infections, Adenovirus Infection, BK Virus Infection, JC Virus Infection, Viral Infections Post-Transplant, Post-Allogeneic Stem Cell Transplant Complications

Sex: All

Ages: N/A – 17 Years

Sponsor: Baylor College of Medicine

Summary

This Expanded Access Program (EAP) allows qualified physicians within Texas to obtain access to multivirus-specific cytotoxic T lymphocytes (VSTs) developed under Baylor College of Medicine's TETRAVI program (NCT04013802) for the treatment of persistent or recurrent infections with EBV, CMV, adenovirus, or BK virus in pediatric patients being treated in Texas who have received allogeneic stem cell transplants and have no other suitable therapeutic options.

Eligibility Criteria

Inclusion Criteria: * Patients \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07104591). StuddyBuddy aggregates publicly available trial information.